Arkolith/Insider Trading/TCON/Form 4

Theuer Charles

President and CEO, DirectorTracon Pharmaceuticals, Inc. (TCON) · full profile →Form 4 · filed Nov 22, 2022
Net Buying
Open-Market Buys
$20K
Open-Market Sells
$0
Net Open-Market Flow
$20K
Transactions
1
1 non-derivative · 0 derivative

Non-Derivative Transactions (Table I)

DateActionSharesPriceValueOwned After
Nov 18, 2022Buy(P)14K$1.41$20K310K

Transaction Codes

P
Open-market purchase

Data Source & Provenance

Parsed from a single SEC EDGAR Form 4 filing (accession 0001209191-22-058302) within minutes of acceptance. Every field above traces to the original document. Verify it directly:

View original filing on SEC.govRaw Form 4 XML